FKBP51 和 FKBP52 在信号转导和疾病中的作用。
FKBP51 and FKBP52 in signaling and disease.
机构信息
The Border Biomedical Research Center and Department of Biological Sciences, University of Texas at El Paso, El Paso, TX 79968, USA.
出版信息
Trends Endocrinol Metab. 2011 Dec;22(12):481-90. doi: 10.1016/j.tem.2011.08.001. Epub 2011 Aug 31.
Abstract
FKBP51 and FKBP52 are diverse regulators of steroid hormone receptor signaling, including receptor maturation, hormone binding and nuclear translocation. Although structurally similar, they are functionally divergent, which is largely attributed to differences in the FK1 domain and the proline-rich loop. FKBP51 and FKBP52 have emerged as likely contributors to a variety of hormone-dependent diseases, including stress-related diseases, immune function, reproductive functions and a variety of cancers. In addition, recent studies have implicated FKBP51 and FKBP52 in Alzheimer's disease and other protein aggregation disorders. This review summarizes our current understanding of FKBP51 and FKBP52 interactions within the receptor-chaperone complex, their contributions to health and disease, and their potential as therapeutic targets for the treatment of these diseases.
摘要
FKBP51 和 FKBP52 是类固醇激素受体信号转导的多样化调节剂，包括受体成熟、激素结合和核转位。尽管结构相似，但它们在功能上是不同的，这主要归因于 FK1 结构域和富含脯氨酸的环的差异。FKBP51 和 FKBP52 已成为多种激素依赖性疾病的可能贡献者，包括与应激相关的疾病、免疫功能、生殖功能和多种癌症。此外，最近的研究表明 FKBP51 和 FKBP52 与阿尔茨海默病和其他蛋白质聚集障碍有关。本综述总结了我们目前对受体伴侣复合物中 FKBP51 和 FKBP52 相互作用的理解，它们对健康和疾病的贡献，以及它们作为治疗这些疾病的治疗靶点的潜力。
相似文献
1
FKBP51 and FKBP52 in signaling and disease.FKBP51 和 FKBP52 在信号转导和疾病中的作用。
Trends Endocrinol Metab. 2011 Dec;22(12):481-90. doi: 10.1016/j.tem.2011.08.001. Epub 2011 Aug 31.
2
Structural and biochemical insights into FKBP51 as a Hsp90 co-chaperone.FKBP51作为Hsp90共伴侣蛋白的结构与生化见解
J Cell Biochem. 2024 Dec;125(12):e30384. doi: 10.1002/jcb.30384. Epub 2023 Feb 15.
3
Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology.辅助伴侣蛋白Fkbp52而非Fkbp51在雄激素受体介导的信号传导和生理过程中起关键作用。
J Biol Chem. 2007 Feb 16;282(7):5026-5036. doi: 10.1074/jbc.M609360200. Epub 2006 Dec 1.
4
Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease.FKBP52共伴侣蛋白在类固醇激素受体调节的生理和疾病中的治疗靶点
Curr Mol Pharmacol. 2015;9(2):109-25. doi: 10.2174/1874467208666150519114115.
5
Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling.FKBP52肽基脯氨酰异构酶结构域在类固醇激素信号调节中的非催化作用。
Mol Cell Biol. 2007 Dec;27(24):8658-69. doi: 10.1128/MCB.00985-07. Epub 2007 Oct 15.
6
Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52.免疫亲和素 FKBP51 和 FKBP52 的 TPR 结构域的分子伴侣活性和生物调节作用。
Curr Protein Pept Sci. 2014 May;15(3):205-15. doi: 10.2174/1389203715666140331113753.
7
Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins.51 kDa FK506结合蛋白（FKBP51）N端结构域与其与类固醇受体蛋白相互作用位点附近的构象转变偶联
J Biol Chem. 2015 Jun 19;290(25):15746-15757. doi: 10.1074/jbc.M115.650655. Epub 2015 May 7.
8
Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52.FKBP51 和 FKBP52 的 FK506 结合结构域中紧密同源的构象动力学差异。
Biochem J. 2014 Jul 1;461(1):115-23. doi: 10.1042/BJ20140232.
9
The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.糖皮质激素受体配体结合域中的螺旋1-3环是FKBP共伴侣蛋白的一个调节元件。
Mol Endocrinol. 2013 Jul;27(7):1020-35. doi: 10.1210/me.2012-1023. Epub 2013 May 17.
10
FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity.FK506结合蛋白52磷酸化：调节类固醇激素受体活性的潜在机制。
Mol Endocrinol. 2007 Dec;21(12):2956-67. doi: 10.1210/me.2006-0547. Epub 2007 Aug 23.
引用本文的文献
1
HSP90 and the cancer transcriptome: a comprehensive review of inhibitors and mechanistic insights.热休克蛋白90与癌症转录组：抑制剂及机制见解的全面综述
Int J Clin Oncol. 2025 May 18. doi: 10.1007/s10147-025-02782-6.
2
Assessment of prognosis and responsiveness to immunotherapy in colorectal cancer patients based on the level of immune cell infiltration.基于免疫细胞浸润水平评估结直肠癌患者的预后及免疫治疗反应性。
Front Immunol. 2025 Feb 3;16:1514238. doi: 10.3389/fimmu.2025.1514238. eCollection 2025.
3
Profiling Genome-Wide Methylation Patterns in Cattle Infected with .对感染了……的牛进行全基因组甲基化模式分析
Int J Mol Sci. 2024 Dec 26;26(1):89. doi: 10.3390/ijms26010089.
4
FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis.FKBP4 通过 p53/HK2 轴促进糖酵解和肝细胞癌进展。
Sci Rep. 2024 Nov 6;14(1):26893. doi: 10.1038/s41598-024-78383-6.
5
Targeting glucocorticoid receptor signaling pathway for treatment of stress-related brain disorders.靶向糖皮质激素受体信号通路治疗与应激相关的脑疾病。
Pharmacol Rep. 2024 Dec;76(6):1333-1345. doi: 10.1007/s43440-024-00654-w. Epub 2024 Oct 3.
6
Transcriptome changes in humans acutely exposed to nanoparticles during grinding of dental nanocomposites.人类在研磨牙科纳米复合材料时急性暴露于纳米颗粒后转录组的变化。
Nanomedicine (Lond). 2024 Jul 14;19(17):1511-1523. doi: 10.1080/17435889.2024.2362611. Epub 2024 Jul 2.
7
The Role of FKBPs in Complex Disorders: Neuropsychiatric Diseases, Cancer, and Type 2 Diabetes Mellitus.FKBP 在复杂疾病中的作用：神经精神疾病、癌症和 2 型糖尿病。
Cells. 2024 May 8;13(10):801. doi: 10.3390/cells13100801.
8
Methylation Patterns of the FKBP5 Gene in Association with Childhood Maltreatment and Depressive Disorders.FKBP5 基因甲基化模式与儿童期虐待和抑郁障碍的关联。
Int J Mol Sci. 2024 Jan 25;25(3):1485. doi: 10.3390/ijms25031485.
9
Heat shock protein 90: biological functions, diseases, and therapeutic targets.热休克蛋白90：生物学功能、疾病及治疗靶点
MedComm (2020). 2024 Jan 25;5(2):e470. doi: 10.1002/mco2.470. eCollection 2024 Feb.
10
Cryo-EM reveals how Hsp90 and FKBP immunophilins co-regulate the glucocorticoid receptor.冷冻电镜揭示了 Hsp90 和 FKBP 免疫亲和素如何共同调节糖皮质激素受体。
Nat Struct Mol Biol. 2023 Dec;30(12):1867-1877. doi: 10.1038/s41594-023-01128-y. Epub 2023 Nov 9.
本文引用的文献
1
Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study.FKBP5 基因变异与不良生活事件在预测抑郁症发病中的相互作用：一项为期 10 年的前瞻性社区研究结果。
Am J Psychiatry. 2011 Oct;168(10):1107-16. doi: 10.1176/appi.ajp.2011.10111577. Epub 2011 Aug 24.
2
Targeting the regulation of androgen receptor signaling by the heat shock protein 90 cochaperone FKBP52 in prostate cancer cells.靶向雄激素受体信号转导的热休克蛋白 90 伴侣 FKBP52 在前列腺癌细胞中的作用。
Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11878-83. doi: 10.1073/pnas.1105160108. Epub 2011 Jul 5.
3
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity.FKBP51—糖皮质激素和雄激素敏感性的选择性调节剂。
Curr Opin Pharmacol. 2011 Aug;11(4):332-7. doi: 10.1016/j.coph.2011.04.012. Epub 2011 May 11.
4
Regulation of steroid hormone receptor function by the 52-kDa FK506-binding protein (FKBP52).甾体激素受体功能的调节FK506 结合蛋白（FKBP52）的 52kDa。
Curr Opin Pharmacol. 2011 Aug;11(4):314-9. doi: 10.1016/j.coph.2011.03.010. Epub 2011 Apr 19.
5
Hsp90 can accommodate the simultaneous binding of the FKBP52 and HOP proteins.热休克蛋白90（Hsp90）能够容纳FKBP52和HOP蛋白的同时结合。
Oncotarget. 2011 Jan-Feb;2(1-2):43-58. doi: 10.18632/oncotarget.225.
6
Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach.皮质醇分泌与抑郁症状的遗传学研究：候选基因与全基因组关联分析
Psychoneuroendocrinology. 2011 Aug;36(7):1053-61. doi: 10.1016/j.psyneuen.2011.01.003. Epub 2011 Feb 12.
7
NF-κB in immunobiology.NF-κB 在免疫生物学中的作用。
Cell Res. 2011 Feb;21(2):223-44. doi: 10.1038/cr.2011.13. Epub 2011 Jan 18.
8
NF-κB, inflammation, and metabolic disease.NF-κB、炎症与代谢性疾病。
Cell Metab. 2011 Jan 5;13(1):11-22. doi: 10.1016/j.cmet.2010.12.008.
9
FK506 binding proteins as targets in anticancer therapy.FK506 结合蛋白作为抗癌治疗的靶点。
Anticancer Agents Med Chem. 2010 Nov 1;10(9):651-6. doi: 10.2174/187152010794479816.
10
Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle.混合的 HSP90-共伴侣复合物对于反应循环的进展很重要。
Nat Struct Mol Biol. 2011 Jan;18(1):61-6. doi: 10.1038/nsmb.1965. Epub 2010 Dec 19.
Zotero 插件